ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 237677 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 237677; 2) Community: the network communities that were significantly associated with the response to NSC 237677; 3) Molecule: the relationships between components within communities and NSC 237677; 4) MDR: the compounds that were significantly associated with the NSC 237677.

NSC Compound Enrichment Correlation
NSC 673787 Null 0.049093561024907 0.29741317
NSC 677586 Null 0.049093561024907 0.056105547
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.049093561024907 0.60210038
NSC 681632 Camptothecin Derivative 0.049093561024907 0.13091365
NSC 683515 Null 0.049093561024907 0.23897673
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.049093561024907 0.38791923
NSC 687578 Null 0.049093561024907 0.13017334
NSC 693135 Null 0.049093561024907 0.49638747
NSC 693883 Acetaldehyde, 1-chloro-, O-[[(4-fluoro-3-nitrophenyl) amino]carbonyl]oxime 0.049093561024907 0.42107943
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.049093561024907 0.45553861
Total:104  Current:101    [First] [Prev] [Next] [Last]